Diverse mechanisms of β-catenin deregulation in ovarian endometrioid adenocarcinomas

Cancer Research

Volumn 61, Issue 22, 2001, Pages 8247-8255

  Wu, R ^a   Zhai, Y ^a   Fearon, E R ^a   Cho, K R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; COMPLEMENTARY DNA; DNA; RNA;

ARTICLE; CARCINOGENESIS; DEREGULATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ADULT; AGED; BETA CATENIN; CARCINOMA, ENDOMETRIOID; CELL NUCLEUS; CYTOSKELETAL PROTEINS; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, APC; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MIDDLE AGED; MUTATION; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROTEINS; REPRESSOR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0035890615     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Cancer statistics, 2000
2. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: Does the emperor have no clothes?
3. The biology of ovarian cancer
4. Genetic factors in ovarian carcinoma
5. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer
6. Precursor lesions of ovarian epithelial malignancy
7. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors
8. Microsatellite instability and alterations in the hMSH 2 gene in human ovarian cancer
9. Microsatellite instability in ovarian neoplasms
10. Frequent nuclear β-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation
11. Mutational analysis of β-catenin gene in Japanese ovarian carcinomas: Frequent mutations in endometrioid carcinomas
12. Mutations in the β-catenin gene (CTNNB1) in endometrioid ovarian carcinomas
13. β-catenin expression pattern in stage I and Il ovarian carcinomas: Relationship with β-catenin gene mutations. Clinicopathological features, and clinical outcome
14. β-catenin mutation and expression analysis in ovarian cancer: Exon 3 mutations and nuclear translocation in 16% of endometrioid tumours
15. Wnt signaling: A common theme in animal development
16. Wnt signaling and cancer
17. Wnt signaling in oncogenesis and embryogenesis - A look outside the nucleus
18. Identification of c-MYC as a target of the APC pathway
19. The cyclin DI gene is a target of the β-catenin/LEF-I pathway
20. β-catenin regulates expression of cyclin D1 in colon carcinoma cells
21. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors
22. The oncogenic activation of β-catenin
23. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein
24. Activation of β-catenin-TCF signaling in colon cancer by mutations in β-catenin or APC
25. Sequence variants of the AXIN gene in breast, colon, and other cancers: An analysis of mutations that interfere with GSK3 binding
26. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
27. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating β-catenin/TCF signalling
28. β- and γ-catenine mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer
29. Cadherins and catenins: Role in signal transduction and tumor progression
30. Plakoglobin and β-catenin: Protein interactions, regulation and biological roles
31. Loss of heterozygosity on chromosome 5 in sporadic ovarian carcinoma is a late event and is not associated with mutations in APC at 5q21-22
32. γ-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin
33. Surface epithelial-stromal tumors of the ovary
34. Rare activation of the TCF/β-catenin pathway in ovarian cancer
35. Inhibition of Wnt signaling by ICAT, a novel β-catenin-interacting protein
36. Down-regulation of β-catenin by human AXIN and its association with the APC tumor suppressor, β-catenin and GSK3β
37. Identification of novel polymorphisms in the AXIN1 and CDX-2 genes
38. Somatic mutations of the PPP2RIB candidate tumor suppressor gene at chromosome 11q23 are infrequent in ovarian carcinomas
39. β-catenin mutations in cell lines established from human colorectal cancers
40. Stabilization of β-catenin by genetic defects in melanoma cell lines
41. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the β-catenin gene
42. Sporadic medulloblastomas contain oncogenic β-catenin mutations
43. β-catenin mutations in human prostate cancer
44. Detection and analysis of β-catenin mutations in prostate cancer
45. β-catenin mutation in carcinoma of the uterine endometrium
46. β-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway
47. β-catenin mutations and aberrant nuclear expression during endometrial tumorigenesis
48. Mutational analysis of the CTNNBI and APC genes in uterine endometrioid carcinoma
49. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament
50. Evidence for the colonic origin of ovarian cancer cell line SW626
51. Ovarian atypical endometriosis: Its close association with malignant epithelial tumours
52. Interaction of AXIN and Dvl-2 proteins regulates Dvl-2-stimulated TCF-dependent transcription
53. GSK-3β-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by β-catenin and protein phosphatase 2A complexed with AXIN
54. PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs
55. Gastrin is a target of the β-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis
56. Identification of connexin43 as a functional target for Wnt signalling
57. WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumors